Complex physiological stimuli differentially regulate the tissuespecific transcription of the lipoprotein lipase (LPL) gene. A conserved DNA recognition element (Ϫ171 to Ϫ149 bp) within the promoter functions as a transcriptional enhancer when bound by the peroxisome proliferator-activated receptor-␥ 2 (PPAR␥ 2 )/retinoid X receptor ␣ (RXR␣) heterodimer, but serves as a transcriptional silencer in the presence of unidentified double and single stranded DNA-binding proteins. To address this apparent paradox, the current study examined the effect of two classes of candidate comodulatory proteins, COUP-TF (chicken ovalbumin upstream promoter transcriptional factor) and the corepressor SMRT (silencing mediator of retinoic acid receptor and thyroid receptor). The expression of COUP-TF was detected by Western and Northern blots in a preadipocyte 3T3-L1 cell model during periods corresponding to increased LPL transcription.
L IPOPROTEIN lipase (LPL; EC 3.1.1.34) is the enzyme that hydrolyzes triglycerides into FFA (1) . It is responsible for the clearance of chylomicrons from the circulation, and its dysregulation contributes to cardiovascular disease (1) . A multitude of hormonal and cytokine cues account for the complex physiological expression of LPL in mammary epithelial cells, macrophages, hepatocytes, and adipocytes (1) . Nuclear hormone receptor ligands such as thiazolidinediones [peroxisome proliferator-activated receptors (PPARs)] or hydrocortisone (glucocorticoid receptor) induce LPL transcription, whereas proinflammatory cytokines, such as tumor necrosis factor-␣, are inhibitory (1) . These actions are mediated through specific DNA recognition elements located within the LPL promoter. Recent studies have determined that the peroxisome proliferator-activated receptor ␥ 2 (PPAR␥ 2 )/retinoid X receptor (RXR) heterodimer binds to the murine and human LPL promoters between Ϫ171 to Ϫ149 bp relative to the transcriptional start site (2, 3) ; this identical sequence is conserved in the rat LPL promoter (4) . In cotransfection analyses performed in the 293T cell line, PPAR␥ 2 /RXR␣ binding to the murine LPL promoter increased reporter gene expression by 13-fold in the absence of exogenous ligand, with a further 2.5-fold induction upon the addition of thiazolidinediones, demonstrating that the PPAR recognition element (PPRE) acts as an enhancer (3) . However, independent transfection studies performed in HeLa cells had associated the identical sequence element (Ϫ169 to Ϫ151 bp) in the human LPL promoter with a silencer function (5) . This repressor activity was attributed to unknown double and single stranded DNA-binding proteins (5) .
Two classes of proteins could account for this paradoxical association of a single PPRE with both enhancer and silencer activities. One class is the chicken ovalbumin upstream promoter transcription factor (COUP-TF) family, which includes COUP-TFI or erbA-related protein-3 (EAR3), COUP-TFII or apolipoprotein AI regulatory protein-1 (ARP-1), and EAR2 (6 -8) . The COUP-TF proteins bind to nuclear receptor recognition elements separated by a single nucleotide (DR1), similar to those recognized by PPAR proteins (7, 9) . The COUP-TF proteins have been associated with both repression (reviewed in Ref. 8 ) and activation (8, 10 -13) of promoters regulated by nuclear hormone receptors. The COUP-TF proteins are expressed in a number of tissues, including preadipocytes (8, 14) .
A second class of candidate proteins is the recently described corepressors (15, 16) . These proteins interact directly with nuclear hormone receptors in the absence of ligand to repress transcriptional activation from promoters regulated by nuclear hormone receptors (15, 16) . The messenger RNAs (mRNAs) of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and the nuclear corepressor (N-CoR) are expressed ubiquitously in all tissues examined as well as in the 293, HeLa, and 3T3 cell lines (17) . Although the PPAR␥ 2 /RXR heterodimer has been found to bind strongly to SMRT and N-CoR in solution, their interactions on DNA have been reported as weak (SMRT) or nonexistent (N-CoR) (18) . In cotransfection analyses performed in 293T cells, SMRT exhibited less than 2-fold repression of the acylcoenzyme A oxidase PPRE in the presence of PPAR␥, whereas N-CoR had no significant effect (18) . This led to the conclusion that weak binding between PPAR␥ and corepressors on DNA resulted in an inability of the protein complex to repress transcription from the acyl-coenzyme A oxidase PPRE; however, "the ability of PPAR␥ to interact with corepressor in solution raised the possibility that PPAR␥ could repress transcription on other sites or in other cell types" (18) .
This study set out to investigate the modulatory effects of COUP-TF family members and SMRT on PPAR␥ 2 /RXR␣-mediated transcriptional activation of the murine LPL promoter. The data demonstrate that COUP-TF proteins potentiated PPAR␥ 2 /RXR␣-mediated transcriptional activation in 293T cells. In contrast, SMRT repressed PPAR␥ 2 /RXR␣-mediated transcription from the LPL promoter, independent of the presence of COUP-TFII (ARP-1). 
Materials and Methods Materials

Plasmids
Constructs containing varying segments of the wild-type murine LPL promoter linked to the luciferase reporter gene were prepared in the p19Luc vector (provided by D. R. Helinski, University of California-San Diego, La Jolla, CA) (19) as previously described (3). The pEF-BOS plasmid (20) was used to prepare eukaryotic expression vectors containing the following complementary DNAs (cDNAs): murine PPAR␥ 2 (21), murine RXR␣ (22) (provided by R. Evans, The Salk Institute, La Jolla, CA), human COUP-TFII (ARP-1) (23), human COUP-TFI (EAR-3), and human EAR-2 (24) (all human cDNAs were provided by J. Ladias, Beth Israel Hospital, Boston, MA). The pAB⌬gal vector was used to prepare eukarytoic expression constructs containing cDNAs encoding the following amino acids of the human SMRT protein: full-length construct (1-1495), 29 -564, 565-1289, and 565-1495. The pT7 vector was used to prepare bacterial expression constructs encoding the following amino acids of the human SMRT protein: full-length construct (1-1495), 
Transient transfections
The human embryonic kidney cell line 293T (27) (provided by K. Oritani, Oklahoma Medical Research Foundation, Oklahoma City, OK), was maintained in DMEM supplemented with 10% FBS (HyClone Laboratories, Inc., Logan, UT), 100 U/ml penicillin, and 100 g/ml streptomycin. A total of 8 ϫ 10 4 cells in a 2-ml volume were plated in 35-mm dishes 18 h before transfection. A calcium phosphate/DNA coprecipitate was prepared by mixing 83 l 1 mm Tris-HCl (pH 8.0) and 0.1 mm EDTA (pH 8.0) containing up to 12 g DNA with 12.5 l 2 m CaCl 2 and 91.5 l 2 ϫ HEPES-buffered saline (280 mm NaCl, 10 mm KCl, 1.5 mm Na 2 PO 4 , 12 mm dextrose, and 50 mm HEPES, pH 7.05). After 25 min, the entire volume was added to the cells in fresh medium. After overnight incubation, the cell medium was replaced. Cells were harvested 48 h after transfection in a 100-l volume of 25 mm glycylglycine, 15 mm MgSO 4 , 1 mm dithiothreitol (DTT), and 1% Triton X-100. Protein concentrations were determined using the bicinchonic acid method (Pierce Chemical Co., Rockford, IL). Luciferase assays were performed over a 20-sec reaction period using aliquots of 87.5 g protein in a 125-l volume containing 0.5 mm d-luciferin, 2.5 mm ATP, 7.5 mm MgSO 4 , and 100 mm KH 2 PO 4 . Assays were performed using a Monolight 2010 Luminometer (Analytical Luminescence Laboratory, San Diego, CA). All transfection analyses were performed a minimum of three times and were analyzed by one-way ANOVA and Student-Newman-Keuls multiple comparison test. Minimal criteria for significance were determined by P Յ 0.05.
Adipocyte differentiation and tissue culture
The murine preadipocyte cell line 3T3-L1 was plated in 2 ml DMEM supplemented with 10% bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin at a density of 2.5 ϫ 10 5 cells/35-mm plate. After 4 -7 days, when the cells had reached confluence, the medium was replaced with fresh medium containing 10% FBS supplemented with 1 m dexamethasone, 500 m methylisobutylxanthine, and 5 g/ml insulin. Cells were maintained in this induction medium for 3-4 days before returning to the unsupplemented medium. Individual cultures were harvested at varying time intervals (0 -8 days) for RNA (in 0.5 ml 4 m guanidine isothiocyanate solution) or for immunoblots [in 100 l 50 mm Tris (pH 7.4), 150 mm NaCl, 0.025% NaN 3 , 0.5% Nonidet P-40, 0.25% deoxycholate, 1 mm phenylmethylsulfonylfluoride, 0.5 mm sodium vanadate, 0.1 mm sodium molybdate, and 1 g/ml leupeptin and aprotinin].
Electromobility shift assays
The DNA electromobility shift assays were performed using a 67-bp HindIII/SspI DNA fragment spanning bp Ϫ181 to Ϫ113 of the murine LPL promoter (3). DNA labeling was performed using T4 polynucleotide kinase and [␥-
32 P]deoxy-ATP (ICN, Irvine, CA). Probes were labeled to a specific activity of 10 5 -10 6 cpm/pmol. Reactions were conducted in a 30-l volume containing 10 mm Tris (pH 8.0), 0.1 m KCl, 0.05% Nonidet P-40, 1 mm DTT, 6% glycerol, 0.5 ng recombinant COUP-TFII (ARP-1; provided by R. Vega and D. Kelly, Washington University, St. Louis, MO), and 2-10 ϫ 10 5 cpm probe for a 20-min period at room temperature. Reactions were performed in the absence or presence of competitor DNA fragments spanning bp Ϫ181 to ϩ187 of the LPL promoter. In addition to the wild-type sequence, the following mutations (underlined) in the PPAR␥ recognition element were used: DNA sequence mutation sites: wild type (Ϫ181 bp), gctttccttcctgccctttccccttcttctcgctgg; mutant A (Ϫ181 bp), gctttccttaaaaaaatttccccttcttctcgctgg (Ϫ172 to Ϫ166 bp); mutant B (Ϫ181 bp), gctttccttcctgaaaaaaacccttcttctcgctgg (Ϫ168 to Ϫ162 bp); mutant C (Ϫ181 bp), gctttccttcctgccctaaaaaaatcttctcgctgg (Ϫ164 to Ϫ158 bp); mutant D (Ϫ181 bp), gctttccttcctgccctttccaaaaaaactcgctgg (Ϫ160 to Ϫ154 bp); and mutant E (Ϫ181 bp), gctttccttcctgccctttccccttaaaaaaactgg (Ϫ156 to Ϫ150 bp). Samples were separated on a 5% acrylamide/bis-acrylamide (24:1) gel by electrophoresis at 100 V for 3 h. Gels were dried at 80 C for 90 min and exposed to Kodak XAR film (Eastman Kodak Co., Rochester, NY) for 18 h without an intensifying screen.
In vitro transcription/translation
In vitro transcription was performed using the T7 RNA polymerase and circular plasmids containing varying segments of the human SMRT cDNA in the pT7 vector or containing the full-length coding region of the human COUP-TFII (ARP-1) cDNA in the pBluescript SKII vector. In vitro translation was performed with rabbit reticulocyte lysates (Promega Corp., Madison, WI). Protein products were radiolabeled with [ 35 S]methionine (ICN). Control reactions were performed with a luciferase cDNA provided by the manufacturer, which yielded a 62-kDa product.
In vitro pull-down assays
The pGEX2T vectors containing either no insert or the PPAR␥ 1 cDNA encoding amino acids 174 -475 were transformed into the bacterial strain BL21 (DE3) pLysS, cultured at 20 -24 C to an OD 592 of 0.6 -0.8, induced with a final concentration of 1 mm isopropyl ␤-d-thiogalactopyranoside, pelleted by centrifugation at 4 C, and stored at Ϫ70 C. Aliquots from 200 ml bacterial culture were suspended in 20 ml lysis buffer [50 mm Tris (pH 8.0), 250 mm KCl, 1 mm dithiothreitol, 1 mm phenylmethylsulfonylfluoride, and 1% Triton X-100], frozen and thawed three times, and centrifuged. Expression of the GST fusion proteins was confirmed by electrophoresis of the lysates on SDS-PAGE gels followed by either Coomassie staining or immunoblotting with polyclonal antibodies directed against either GST or the C-terminal peptide of PPAR␥ (28) . The cleared lysate was mixed with 300 l prewashed glutathione-Sepharose 4B beads (Pharmacia Biotech, Alameda, CA) and rocked overnight at 4 C. After four washes in 1.4 ml washing buffer [60 mm NaCl, 20 mm Tris (pH 8.0), 6 mm MgCl 2 , 1 mm DTT, 1 mm EDTA, 8% glycerol, and 0.05% Nonidet P-40], 200-l aliquots of beads were mixed with 10-l volumes of in vitro transcribed and translated proteins and incubated overnight at 4 C. The samples were washed five times in NENT buffer [500 mm NaCl, 20 mm Tris (pH 8.0), 6 mm MgCl 2 , 1 mm DTT, 1 mm EDTA, 8% glycerol, and 0.5% Nonidet P-40], suspended in 20 l SDS loading buffer, heated to 95 C for 5 min, and resolved on a 12% acrylamide SDS-PAGE gel. Control lanes contained 10% of the input labeled protein used for binding. The gel was fixed, treated with EN 3 HANCE (New England Nuclear-DuPont, Boston, MA), dried at 60 C, and exposed to autoradiographic film for 1-7 days with an enhancer screen.
Northern and Western blots
Total RNA harvested from 3T3-L1 cells on days 0 -6 was prepared as previously described (28, 29) . Northern blots were performed with aliquots of 10 g total RNA electrophoresed on 1% agarose-0.66% formaldehyde gels, transferred to ZetaProbe membranes (Bio-Rad Laboratories, Inc., Richmond, CA), and hybridized overnight at 55 C in 500 mm sodium phosphate, pH 7.4, and 7% SDS (30) with random primed radiolabeled probes for murine LPL, murine COUP-TFII, or actin (31) . Blots were washed in 40 mm sodium phosphate and 1% SDS at a maximum stringency of 55 C and exposed for 1 day with an enhancer screen at Ϫ70 C. Western blots were performed with aliquots of 50 g 3T3-L1 protein lysates electrophoresed on 10% acrylamide SDS-PAGE gels, transferred to nitrocellulose paper, blocked with 5% nonfat dry milk in PBS-0.1% Tween (PBST), and immunoblotted overnight at 4 C with a primary rabbit antibody directed against COUP-TF (32) or C/EBP␣ (SC061, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in 1% nonfat dry milk-PBST. The blots were rinsed in PBST, incubated with goat antirabbit antibody coupled to horseradish peroxidase (1:10,000 dilution in PBST with 0.25% nonfat dry milk; Bio-Rad Laboratories, Inc.), and the protein immunostaining was detected by chemiluminescence (ECL kit, Amersham, Arlington Heights, IL).
Results
Effect of adipogenic agonists on expression of COUP-TFII (ARP-1) in 3T3-L1 preadipocytes
Initial studies were performed to document the expression of COUP-TFII (ARP-1) mRNA and protein in response to agents known to induce LPL transcription. Northern blot analysis demonstrated that the preadipocyte cell line 3T3-L1 rapidly increased LPL transcription after exposure to the adipogenic agonists dexamethasone, insulin, and methylisobutylxanthine ( Fig. 1A) (33, 34) . The confluent 3T3-L1 cells expressed COUP-TFII mRNA throughout the induction period; signal remained present from days 0 -8 (Fig. 1A) . Actin served as a control for relative RNA loading between lanes. Western blot analysis performed with protein extracts from similarly treated cells detected COUP-TF protein throughout the induction period (0 -48 h). The protein remained at detectable levels for up to 96 h after induction. This coincided with the peak expression of the late appearing adipogenic transcription factor, C/EBP␣ (Fig. 1B) (35) . These studies document the presence of a COUP-TF protein at times corresponding to induction of the LPL transcript in a preadipocyte cell model (33, 34) . 
Members of the COUP-TF family activate transcription from the murine LPL promoter in synergy with PPAR␥ 2 /RXR␣
In the next series of experiments, cotransfections were designed to determine the effects of COUP-TFI (EAR3), COUP-TFII (ARP-1), and EAR2 on murine LPL transcription in the absence or presence of PPAR␥ 2 /RXR␣ (Fig. 2) . Transfections were performed in 293T cells with the individual nuclear hormone receptor expression constructs alone or in varied combinations. The reporter construct contained Ϫ1824 to ϩ187 bp of the LPL promoter linked to luciferase. The COUP-TF family members alone increased expression from the LPL promoter by less than an order of magnitude; the most potent was COUP-TFII (ARP-1; 9.8-fold). This contrasted to a 15.9-fold activation by PPAR␥ 2 and RXR␣ together. Overexpression of any COUP-TF member with either the PPAR␥ 2 or RXR␣ expression construct alone did not increase transcription further. However, simultaneous expression of either COUP-TFII (ARP-1) or COUP-TFI (EAR3) with PPAR␥ 2 and RXR␣ increased luciferase activity by 101-and 45-fold relative to the baseline. Control experiments substituting vitamin D 3 expression constructs for COUP-TF did not increase PPAR␥ 2 /RXR␣-mediated activation of the LPL promoter (n ϭ 2; data not shown). The actions of COUP-TFII (ARP-1) were concentration dependent (Fig. 3) . Transcription rose in a dose-dependent manner as the ratio of the COUP-TFII (ARP-1) expression plasmid was increased relative to the PPAR␥ 2 and RXR␣ plasmids.
Additional investigations examined the interaction of COUP-TFII (ARP-1) with the PPRE in the presence of PPAR␥ 2 and RXR␣. Cotransfection analyses of LPL promoter deletion constructs with the combination of PPAR␥ 2 , RXR␣, and COUP-TFII (ARP-1; Fig. 4A ) indicated that deletions between bp Ϫ181 to Ϫ101 significantly reduced the fold activation. Levels decreased by a factor of more than 5, comparable to those observed with the same deletion constructs cotransfected with the PPAR␥ 2 /RXR␣ heterodimer alone (3). These data suggested that the PPRE (localized to bp Ϫ171 to Ϫ149) was critical for COUP-TFII (ARP-1) activation. Recombinant COUP-TFII (ARP-1) protein directly bound to the LPL promoter PPRE in electromobility shift assays, giving rise to two mobility-shifted bands, A and B (Fig. 4B) . Competition analyses were performed with a panel of equivalent PCR-generated DNA fragments (bp Ϫ181 to ϩ187). These included a wild-type control and five mutants (A-E) spanning the PPRE from a 5Ј (mutant A) to 3Ј (mutant E) direction. The wild-type control specifically competed for both complexes A and B. In contrast, those DNA fragments containing mutations within the 14 bp at the 5Ј-end of the PPRE (mutants A-C) did not bind the COUP-TFII (ARP-1) protein.
Biochemical studies were performed to determine whether the PPAR␥ and COUP-TFII (ARP-1) protein interacted directly. In vitro pull-down assays detected binding between in vitro transcribed and translated COUP-TFII (ARP-1) protein and the ligand-binding domain of PPAR␥ fused to the GST protein (Fig. 4C) . Control studies did not detect binding of the COUP-TFII (ARP-1) protein with the GST protein alone. Together, these data indicate that COUP-TFII (ARP-1) can interact with both the PPRE and the ligand-binding domain of the PPAR␥ protein itself.
SMRT represses PPAR␥ 2 /RXR␣ activation of transcription from the murine LPL promoter
Previous cotransfection studies by others in 293T cells had demonstrated that the corepressor SMRT bound to the PPAR␥ 2 /RXR␣ heterodimer in solution but had a minimal repressive effect on the acyl-coenzyme A oxidase PPRE (18) . To determine the effect of SMRT on transcription from the murine LPL promoter, the identical cell line was cotransfected with increasing amounts of the SMRT expression construct in the absence (Fig. 5A) or the presence (Fig. 5B ) of COUP-TFII. As the ratio of full-length SMRT expression construct was increased relative to that of the PPAR␥ 2 and RXR␣ plasmids, the fold activation was reduced to the baseline levels observed in the absence of the PPAR␥ 2 /RXR␣ heterodimer (Fig. 5A) . Likewise, as the ratio of full-length SMRT expression plasmid increased relative to that of the COUP-TFII (ARP1), PPAR␥ 2 , and RXR␣ plasmids, the fold activation progressively decreased (Fig. 5B) . Thus, SMRT repressed transcription from the LPL PPRE independent of the presence of COUP-TFII (ARP-1).
To determine the domains of SMRT critical for repression of the LPL PPRE, cotransfection experiments were performed with several SMRT deletion mutants and the wildtype PPAR␥ 2 and RXR␣ (Fig. 6A) . In the absence of SMRT, the PPAR␥ 2 /RXR␣ expression constructs again induced luciferase activity by an order of magnitude relative to baseline. Constructs containing either amino acids 29 -564 or 565-1289 of SMRT reduced this fold activation by 40 -60%. In contrast, A, Activation analysis of LPL promoter deletion constructs by the COUP-TFII (ARP-1) expression construct. The 293T cells were transfected with aliquots of 0.1 g LPL promoter/luciferase reporter constructs containing Ϫ1824, Ϫ564, Ϫ181, or Ϫ101 bp of the 5Ј-flanking region and all extending to ϩ187 bp. Cells were cotransfected with 6 g of the empty pEF-BOS vector or 2 g each of the PPAR␥ 2 , RXR␣, and COUP-TFII (ARP-1) expression constructs. Fold activation is calculated relative to the luciferase baseline in the absence of nuclear hormone receptor expression constructs, defined as 1. Results are normalized to protein concentration (which were maintained at 87.5 g per reaction) and represent the mean Ϯ SE of three experiments. B, Effect of mutations in the PPAR␥ 2 recognition element on COUP-TFII (ARP-1) binding. Electromobility shift assays were conducted using a 67-bp wild-type LPL promoter probe spanning bp Ϫ181 to Ϫ113. Competition experiments were performed using PCR-generated DNA fragments of equivalent size (Ϫ181 to ϩ187 bp) containing either the wild-type sequence or individual, overlapping 7-bp mutations (A-E) spanning the region from Ϫ172 to Ϫ150 bp, as listed in Materials and Methods. Reactions were conducted with recombinant COUP-TFII (ARP-1) protein. Electromobility-shifted complexes are labeled A and B. C, Evidence for a direct interaction between COUP-TFII (ARP-1) and the PPAR␥ ligand-binding domain. In vitro pull-down assays were conducted using [ those constructs containing the carboxyl-terminus of the SMRT protein (amino acids 565-1495 or 1-1495) completely abolished this activation. Further studies employed in vitro pull-down assays to determine whether a direct interaction existed between SMRT and PPAR␥ (Fig. 6B) . Strong interactions (indicated by arrows A, B, and C) were observed between the ligand-binding domain of the PPAR␥/GST fusion protein and all in vitro transcribed and translated proteins containing amino acids 1289 -1495 of SMRT. Radiolabeled proteins lacking the carboxyl-terminal domain of SMRT did not bind to the PPAR␥-GST fusion protein.
Discussion
PPAR␥ interactions with COUP-TF proteins
The COUP-TF proteins increased expression from the LPL promoter synergistically with PPAR␥ 2 /RXR␣ in 293T cells, and this was dependent on the presence of an intact PPRE. This contrasts with many studies that have reported antagonistic actions between COUP-TF and PPAR when compared on a common promoter DNA recognition element. In the majority of cases, transcription was increased by PPAR proteins and decreased by COUP-TF proteins; examples include the promoters for apolipoprotein AI (36), medium chain acyl-coenzyme A dehydrogenase (37, 38) , hydratase dehydrogenase (39, 40) , malic enzyme (41, 42) , and mitochondrial hydroxy-methylglutaryl-coenzyme A synthase (43) . In contrast, the transferrin promoter is the sole example where expression was decreased by PPAR proteins but increased by COUP-TF proteins (13) . Nevertheless, it is likely that the promoters of other hepatic proteins repressed by peroxisome proliferator compounds will exhibit this same profile; candidates include the transthyretin and ␣ 2u -macroglobulin gene promoters (44) .
However, the actions of PPAR and COUP-TF proteins are not necessarily antagonistic. There are examples where both PPAR and COUP-TF actions increase transcription from a common DNA recognition element; these include the human immunodeficiency virus long terminal repeat (10) and the phosphoenolpyruvate decarboxylase promoter (11, 12, 45) . The murine LPL promoter exhibits this same pattern of regulation in the 293T cell line.
This conflicting pattern of both positive and negative interactions with COUP-TF is not unique to PPAR proteins and PPREs. Similar findings with COUP-TF have been reported for the estrogen receptor and estrogen receptor recognition elements (EREs). In a study examining a consensus ERE, COUP-TF proteins were observed to bind to the DNA element and to repress estrogen ligand activation of a reporter gene (46) . In contrast, in studies of the intact estrogen receptor gene promoter containing an ERE, COUP-TF bound to the ERE and increased transcription in synergy with the estrogen receptor (47) . Independent of the mechanism accounting for these disparate interactions between COUP-TF and nuclear hormone receptors, the current findings support the conclusion that COUP-TF proteins can positively modulate LPL promoter transcription through the PPAR recognition element in 293T cells.
PPAR␥ 2 interactions with SMRT
The presence of SMRT repressed PPAR␥ 2 /RXR␣-mediated transcription from the LPL promoter 9-fold. This contrasts with the reported less than 2-fold repression by SMRT of transcription from the isolated acyl-coenyzme A oxidase PPRE (18) . As both studies employed 293T cells, this discrepancy cannot be attributed to differences in the cell model (18) . Instead, the DNA site itself is a more likely explanation (18) . The compositions of the DNA recognition element and its 5Ј-flanking sequences are known to influence PPAR protein binding affinity and specificity (9, 48 -50) . As has been postulated previously (18) , alterations in the DNA sequence could result in conformational changes in the DNA recognition element/PPAR␥ protein complex. This could lead to subsequent allosteric changes in the accessibility of the bound PPAR protein's corepressor-interactive domain to the SMRT protein. Thus, the SMRT protein may regulate PPREs differentially depending on their DNA compositions and flanking sequences. The relative stoichiometry of the SMRT protein relative to the nuclear hormone receptor proteins PPAR␥, RXR and COUP-TF may further contribute to the tissue-specific regulation of LPL. Data supporting a role for SMRT as a PPAR corepressor comes from recent microinjection experiments using anti-SMRT and anti-N-CoR antibodies (51) . In cells transfected with a PPRE-directed reporter gene, injection of an anti-SMRT antibody (but not an anti-N-CoR antibody) relieved PPAR␥-mediated repression induced by stimulation of the mitogen-activated protein kinase cascade (51) .
The current results mapping the PPAR␥ 2 -interactive domain of SMRT to between amino acids 1289 -1495 confirm and extend earlier studies (18) . This region corresponds to one of the two distinct receptor-interactive domains (RID) delineated in the SMRT carboxyl-terminal (RID2, amino acids 1260 -1495) (52) . The PPAR␥ 2 -interactive domain of SMRT is similar to that used by the thyroid receptor (52), but differs from those used by the retinoic acid receptor (RID1, corresponding to amino acids 1086 -1291) (52) and by COUP-TF1 (the amino-terminal portion of SMRT) (25) .
In summary, this work demonstrates that COUP-TFII (ARP-1) and SMRT can modulate transcription from the LPL promoter in the presence of PPAR␥ 2 and RXR␣ in an in vitro system. These observations are consistent with current models suggesting that the relative stochiometry of nuclear receptors and their corepressors regulates promoter function and accounts for cell-specific gene expression (18) . Both COUP-TF and SMRT proteins may play an in vivo role in the complex physiological regulation of LPL. However, the current studies were limited to a single cell line. The 293T cells constitutively express the simian virus 40 T antigen (27) , and the possibility exists that this has contributed to the current findings. Future studies will extend and test these observations in primary adipose tissues and other sites of LPL expression.
